| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |